352 related articles for article (PubMed ID: 8395914)
1. Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family.
He WW; Gustafson ML; Hirobe S; Donahoe PK
Dev Dyn; 1993 Feb; 196(2):133-42. PubMed ID: 8395914
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of a type I serine-threonine kinase receptor for TGF-beta and activin in the rat pituitary tumor cell line GH3.
Takumi T; Moustakas A; Lin HY; Lodish HF
Exp Cell Res; 1995 Jan; 216(1):208-14. PubMed ID: 7813622
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of rat transforming growth factor-beta type II receptor.
Tsuchida K; Lewis KA; Mathews LS; Vale WW
Biochem Biophys Res Commun; 1993 Mar; 191(3):790-5. PubMed ID: 8385453
[TBL] [Abstract][Full Text] [Related]
4. zALK-8, a novel type I serine/threonine kinase receptor, is expressed throughout early zebrafish development.
Yelick PC; Abduljabbar TS; Stashenko P
Dev Dyn; 1998 Apr; 211(4):352-61. PubMed ID: 9566954
[TBL] [Abstract][Full Text] [Related]
5. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity.
ten Dijke P; Ichijo H; Franzén P; Schulz P; Saras J; Toyoshima H; Heldin CH; Miyazono K
Oncogene; 1993 Oct; 8(10):2879-87. PubMed ID: 8397373
[TBL] [Abstract][Full Text] [Related]
6. Identification and developmental expression of two activin receptors in baboon lung.
Zhao Y; Silbajoris R; Young SL
Biochem Biophys Res Commun; 1996 Dec; 229(1):50-7. PubMed ID: 8954082
[TBL] [Abstract][Full Text] [Related]
7. Expression of activin receptor II and IIB mRNA isoforms in mouse reproductive organs and oocytes.
Wu TC; Jih MH; Wang L; Wan YJ
Mol Reprod Dev; 1994 May; 38(1):9-15. PubMed ID: 8049070
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning, genetic mapping, and developmental expression of a bovine transforming growth factor beta (TGF-beta) type I receptor.
Roelen BA; Van Eijk MJ; Van Rooijen MA; Bevers MM; Larson JH; Lewin HA; Mummery CL
Mol Reprod Dev; 1998 Jan; 49(1):1-9. PubMed ID: 9406190
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel isoforms of activin receptor-like kinase 7 (ALK7) generated by alternative splicing and expression of ALK7 and its ligand, Nodal, in human placenta.
Roberts HJ; Hu S; Qiu Q; Leung PC; Caniggia I; Gruslin A; Tsang B; Peng C
Biol Reprod; 2003 May; 68(5):1719-26. PubMed ID: 12606401
[TBL] [Abstract][Full Text] [Related]
10. Concurrent and distinct transcription and translation of transforming growth factor-beta type I and type II receptors in rodent embryogenesis.
Mariano JM; Montuenga LM; Prentice MA; Cuttitta F; Jakowlew SB
Int J Dev Biol; 1998 Nov; 42(8):1125-36. PubMed ID: 9879710
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning, tissue-specific expression, and chromosomal localization of a novel nerve growth factor-regulated G-protein- coupled receptor, nrg-1.
Glickman M; Malek RL; Kwitek-Black AE; Jacob HJ; Lee NH
Mol Cell Neurosci; 1999 Aug; 14(2):141-52. PubMed ID: 10532805
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning of Xenopus activin type I receptor and the analysis of its expression during embryogenesis.
Kondo M; Semba K; Shiokawa K; Yamamoto T
Biochem Biophys Res Commun; 1996 Jan; 218(2):549-55. PubMed ID: 8561794
[TBL] [Abstract][Full Text] [Related]
13. A mammalian serine/threonine kinase receptor specifically binds BMP-2 and BMP-4.
Yamaji N; Celeste AJ; Thies RS; Song JJ; Bernier SM; Goltzman D; Lyons KM; Nove J; Rosen V; Wozney JM
Biochem Biophys Res Commun; 1994 Dec; 205(3):1944-51. PubMed ID: 7811286
[TBL] [Abstract][Full Text] [Related]
14. Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase.
Greenwald J; Fischer WH; Vale WW; Choe S
Nat Struct Biol; 1999 Jan; 6(1):18-22. PubMed ID: 9886286
[TBL] [Abstract][Full Text] [Related]
15. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
Deacu E; Mori Y; Sato F; Yin J; Olaru A; Sterian A; Xu Y; Wang S; Schulmann K; Berki A; Kan T; Abraham JM; Meltzer SJ
Cancer Res; 2004 Nov; 64(21):7690-6. PubMed ID: 15520171
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the MADH2/Smad2 gene, a human Mad homolog responsible for the transforming growth factor-beta and activin signal transduction pathway.
Takenoshita S; Mogi A; Nagashima M; Yang K; Yagi K; Hanyu A; Nagamachi Y; Miyazono K; Hagiwara K
Genomics; 1998 Feb; 48(1):1-11. PubMed ID: 9503010
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning of activin type I and type II receptors and differential regulation of their expression by activin in grass carp pituitary cells.
Song C; Wang X; Zhou H
Gen Comp Endocrinol; 2010 Mar; 166(1):211-6. PubMed ID: 19699739
[TBL] [Abstract][Full Text] [Related]
18. The GS domain of the transforming growth factor-beta type I receptor is important in signal transduction.
Franzén P; Heldin CH; Miyazono K
Biochem Biophys Res Commun; 1995 Feb; 207(2):682-9. PubMed ID: 7864860
[TBL] [Abstract][Full Text] [Related]
19. Cloning and developmental expression of the chick type II and type III TGF beta receptors.
Barnett JV; Moustakas A; Lin W; Wang XF; Lin HY; Galper JB; Maas RL
Dev Dyn; 1994 Jan; 199(1):12-27. PubMed ID: 8167376
[TBL] [Abstract][Full Text] [Related]
20. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the müllerian duct.
Baarends WM; van Helmond MJ; Post M; van der Schoot PJ; Hoogerbrugge JW; de Winter JP; Uilenbroek JT; Karels B; Wilming LG; Meijers JH
Development; 1994 Jan; 120(1):189-97. PubMed ID: 8119126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
